Advanced ChIP-Seq Data Analysis Strategies

July 2014 Webinar

An ongoing problem in ChIP-Seq data analysis is the often large discrepancy between expected changes in histone marks and the actual ChIP-Seq data when using drug treated cells.

In this Webinar, Brian Egan, Epigenetics Services Manager at Active Motif discusses a novel ChIP-Seq spike-in strategy and shows how normalization of ChIP-Seq data using this spike-in strategy reveals the expected changes in the final ChIP-Seq data set for inhibitor treated samples.